Home
About
Products & Services
OoCs
Single/Dual-Chamber Membrane Based Microfluidic Chip
High-Throughput Membrane-Based Microfluidic Chip
High-Throughput Membrane-Free Microfluidic Chip
High-Throughput Co-Culture Chip
Organ Chip Customization Service
Life Science Device
Organ Chip Intelligent Analysis System
Cell Imaging Environment Control System
Organ Chip Flow Controller
Organ Chip Flow Initiation Controller System
Skin chip intelligent analysis system
Liver chip intelligent analysis system
Fully automated skin chip intelligent workstation
Fully automated liver chip intelligent workstation
Ultrafast high-resolution three-dimensional organ chip online imaging and analysis system
Biomodels and Reagents
Cancer organoid Growth Kit
Human-derived organoid Growth Medium
Mouse Organoid Growth Kit
Model Culture Kit
Organoid Growth Relation Reagents
OoCs Solutions
Cancer Drug Sensitivity Analysis
IND Efficacy/Safety Evaluation
Evaluation of Functions/Safety of Cosmetics
Basic Scientific Research
News
Company News
Events
Industry News
Core News Network
Media Promotion
Careers
Contact
中文版
Corporate Briefs
Events Pulse
Industry Insights
Chip Roundup
Media promotion
2026-04-08
Major Policy Announcement: Organoids and Organ-on-a-Chip Technologies Have Been Incorporated into Beijing’s Innovation Development Strategy by Ten Government Departments.
Details>
2026-03-26
Paving the Way with Prestige | Aiwede Bio Honored with the “Innovation Leadership Award” in the Organoid and Organs-on-Chip Industry
2026-03-25
[Conference Invitation] April 1: Shanghai ADC and Novel Antibody Drug Development Conference — Join Aiwed Biotech in exploring evaluation protocols for organ-on-a-chip applications.
2026-03-24
[Breaking News] The world’s first clinical study of a therapeutic, personalized mRNA tumor vaccine that integrates organ-on-a-chip technology with artificial intelligence has officially launched!
2026-03-19
From “Elective” to “Mandatory”: Organ-on-a-Chip Technology Officially Enters the Global Regulatory Evaluation Mainstream
2026-03-17
Aiweide Bio supports the plastic surgery hospital team, driving new advances in in vitro modeling of skin aging.
2026-03-11
The 15th Five-Year Plan sets the tone: organ-on-a-chip technology plus AI unlock a new paradigm for biopharmaceutical innovation.
2026-03-03
Two Sessions Micro-Video | Ai Weide’s Organ-on-a-Chip + AI Unveil a New Paradigm in Precision Medicine
[Limited-Time Free] Join our online training on “Applications of Organ-on-a-Chip Technology in Preclinical Drug Research” on March 5.
2026-03-02
Nature in-depth report: The era of animal experimentation is fading—how are organ-on-a-chip technologies paving the way for the “next step”?
2026-02-11
Growing miniature “hearts,” “livers,” and “tumors” to advance drug development and precision medicine—organ-on-a-chip: a new option for safeguarding human health.
[Xinhua Daily] Cultivating miniature “hearts,” “livers,” and “tumors” to advance drug development and precision medicine—organ-on-a-chip technology: a new frontier in safeguarding human health.